Ignite Creation Date:
2025-12-25 @ 3:18 AM
Ignite Modification Date:
2025-12-26 @ 1:57 AM
Study NCT ID:
NCT06818305
Status:
TERMINATED
Last Update Posted:
2025-12-11
First Post:
2025-01-28
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
Efficacy and Safety of Finerenone and Empagliflozin in Delaying Renal Function Progression After Radical Nephrectomy in High-Risk CKD Patients: A Multicenter RCT
Sponsor:
Jinling Hospital, China
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2025-01-01
Start Date Type:
ACTUAL
Primary Completion Date:
2025-10-01
Primary Completion Date Type:
ACTUAL
Completion Date:
2025-10-01
Completion Date Type:
ACTUAL
First Submit Date:
2025-01-28
First Submit QC Date:
None
Study First Post Date:
2025-02-10
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-12-04
Last Update Post Date:
2025-12-11
Last Update Post Date Type:
ESTIMATED